Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02626572
What this trial is testing

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

Who this might be right for
Alzheimer's Disease
Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Temporarily pausedNCT04520412
What this trial is testing

Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Early research (Phase 1)Study completedNCT00736775
What this trial is testing

The Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01009255
What this trial is testing

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 196
Post-approval studies (Phase 4)Study completedNCT00334906
What this trial is testing

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

Who this might be right for
Alzheimer's Disease
Forest Laboratories 75
Testing effectiveness (Phase 2)Looking for participantsNCT07228078
What this trial is testing

Open-Label Extension Protocol to SNK01-AD01 Study

Who this might be right for
Alzheimer Disease
NKGen Biotech, Inc. 30
Early research (Phase 1)Looking for participantsNCT06535308
What this trial is testing

BnH-015B Clinical Trial in Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BnH Research 92
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205601
What this trial is testing

Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 115
Not applicableStudy completedNCT04404153
What this trial is testing

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Albert Einstein College of Medicine 100
Early research (Phase 1)Study completedNCT02036645
What this trial is testing

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Who this might be right for
Mild-Moderate Alzheimer's DiseaseHealthy Elderly
AstraZeneca 77
Not applicableUnknownNCT03352739
What this trial is testing

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 30
Early research (Phase 1)Study completedNCT00988598
What this trial is testing

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Not applicableStudy completedNCT01893398
What this trial is testing

Multistimulation Group Therapy for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fondazione Don Carlo Gnocchi ETS 60
Not applicableStudy completedNCT00348309
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,496
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Not applicableUnknownNCT04021888
What this trial is testing

The Effects of Exercise Program in Alzheimer's Patients With Mild to Moderate Stage Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAerobic ExerciseBreathing Exercise+1 more
Dokuz Eylul University 60
Testing effectiveness (Phase 2)Study completedNCT01504854
What this trial is testing

Resveratrol for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 119
Testing effectiveness (Phase 2)Study completedNCT03493282
What this trial is testing

Effect of CT1812 Treatment on Brain Synaptic Density

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 43
Testing effectiveness (Phase 2)Study completedNCT06694597
What this trial is testing

Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Fujian Medical University Union Hospital 76
Next Page